FMS vs FXNC

For growth investors, First National Corporation (FXNC) is the stronger pick with 27.

1% revenue growth year-over-year, versus 1. 5% for Fresenius Medical Care AG & Co. KGaA (FMS). Fresenius Medical Care AG & Co. KGaA (FMS) offers the better valuation at 10. 7x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate First National Corporation (FXNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Fresenius Medical Care AG & Co.

KGaA (FMS) is the cheapest at 10. 7x versus First National Corporation at 14. 0x. On forward P/E, Fresenius Medical Care AG & Co. KGaA is actually cheaper at 10. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fresenius Medical Care AG & Co. KGaA wins at 2. 00x versus First National Corporation's 7. 74x.

Over the past 5 years, First National Corporation (FXNC) delivered a total return of +66.

3%, compared to -36. 5% for Fresenius Medical Care AG & Co. KGaA (FMS). Over 10 years, the gap is even starker: FXNC returned +239. 8% versus FMS's -35. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Fresenius Medical Care AG & Co.

KGaA (FMS) is the lower-risk stock at 0. 49β versus First National Corporation's 0. 70β — meaning FXNC is approximately 43% more volatile than FMS relative to the S&P 500. On balance sheet safety, First National Corporation (FXNC) carries a lower debt/equity ratio of 23% versus 76% for Fresenius Medical Care AG & Co. KGaA — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.

1% versus 1. 5% for Fresenius Medical Care AG & Co. KGaA (FMS). On earnings-per-share growth, the picture is similar: First National Corporation grew EPS 96. 0% year-over-year, compared to 82. 6% for Fresenius Medical Care AG & Co. KGaA. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

First National Corporation (FXNC) is the more profitable company, earning 15.

8% net margin versus 5. 0% for Fresenius Medical Care AG & Co. KGaA — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FXNC leads at 19. 6% versus 9. 3% for FMS. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Fresenius Medical Care AG & Co. KGaA (FMS) is the more undervalued stock at a PEG of 2. 00x versus First National Corporation's 7. 74x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Fresenius Medical Care AG & Co. KGaA (FMS) trades at 10. 2x forward P/E versus 11. 6x for First National Corporation — 1. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FMS: 33. 3% to $28. 00.

All stocks in this comparison pay dividends.

Fresenius Medical Care AG & Co. KGaA (FMS) offers the highest yield at 3. 9%, versus 2. 2% for First National Corporation (FXNC).

For long-horizon retirement investors, Fresenius Medical Care AG & Co.

KGaA (FMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 49), 3. 9% yield). Both have compounded well over 10 years (FMS: -35. 6%, FXNC: +239. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FMS (Healthcare) and FXNC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FMS is a mid-cap deep-value stock; FXNC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.